NYSE - Nasdaq Real Time Price • USD
Zimmer Biomet Holdings, Inc. (ZBH)
At close: April 19 at 4:00 PM EDT
After hours: April 19 at 4:09 PM EDT
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 25 | 24 | 27 | 26 |
| Avg. Estimate | 1.87 | 2.02 | 8.06 | 8.68 |
| Low Estimate | 1.8 | 1.96 | 7.85 | 8.27 |
| High Estimate | 1.93 | 2.1 | 8.13 | 8.91 |
| Year Ago EPS | 1.89 | 1.82 | 7.55 | 8.06 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 23 | 22 | 25 | 25 |
| Avg. Estimate | 1.87B | 1.96B | 7.75B | 8.12B |
| Low Estimate | 1.85B | 1.94B | 7.67B | 7.96B |
| High Estimate | 1.91B | 1.98B | 7.8B | 8.29B |
| Year Ago Sales | 1.7B | 1.82B | 7.39B | 7.75B |
| Sales Growth (year/est) | 9.80% | 7.50% | 4.90% | 4.70% |
Earnings History
| CURRENCY IN USD | 3/31/2023 | 6/30/2023 | 9/30/2023 | 12/31/2023 |
|---|---|---|---|---|
| EPS Est. | 1.64 | 1.81 | 1.6 | 2.15 |
| EPS Actual | 1.89 | 1.82 | 1.65 | 2.2 |
| Difference | 0.25 | 0.01 | 0.05 | 0.05 |
| Surprise % | 15.20% | 0.60% | 3.10% | 2.30% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 1.87 | 2.02 | 8.06 | 8.68 |
| 7 Days Ago | 1.87 | 2.02 | 8.06 | 8.68 |
| 30 Days Ago | 1.88 | 2.02 | 8.05 | 8.69 |
| 60 Days Ago | 1.88 | 2.02 | 8.05 | 8.68 |
| 90 Days Ago | 1.91 | 1.97 | 7.94 | 8.51 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | 1 | 1 | -- | 2 |
| Up Last 30 Days | 1 | 1 | 2 | 3 |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | 1 | -- | -- | -- |
Growth Estimates
| CURRENCY IN USD | ZBH | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | -1.10% | -- | -- | 1.60% |
| Next Qtr. | 11.00% | -- | -- | 10.50% |
| Current Year | 6.80% | -- | -- | 5.20% |
| Next Year | 7.70% | -- | -- | 13.30% |
| Next 5 Years (per annum) | 6.93% | -- | -- | 11.22% |
| Past 5 Years (per annum) | 5.05% | -- | -- | -- |
Research Analysis
Analyst Price Targets
Fair Value
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Analyst Recommendations
- Strong Buy
- Buy
- Hold
- Underperform
- Sell
Earnings
Upgrades & Downgrades
| Maintains | Evercore ISI Group: In-Line to In-Line | 4/4/2024 |
| Maintains | Citigroup: Neutral to Neutral | 4/3/2024 |
| Reiterates | Canaccord Genuity: Hold to Hold | 2/23/2024 |
| Maintains | Barclays: Underweight to Underweight | 2/12/2024 |
| Maintains | Truist Securities: Hold to Hold | 2/9/2024 |
| Maintains | JP Morgan: Neutral to Neutral | 2/9/2024 |
Related Tickers
SYK Stryker Corporation
325.43
-0.62%
SNN Smith & Nephew plc
23.84
-0.71%
ZIMV ZimVie Inc.
15.43
-1.59%
EW Edwards Lifesciences Corporation
85.94
-0.59%
CNMD CONMED Corporation
72.64
+2.19%
BSX Boston Scientific Corporation
67.33
-0.13%
STE STERIS plc
199.51
-0.65%
PODD Insulet Corporation
166.25
+0.92%
MDT Medtronic plc
79.48
+0.37%
IRTC iRhythm Technologies, Inc.
112.09
-0.03%